Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

OxyGeni®

The OxyGeni®, combined with the OxySpur® Oxygen Diffusion Dressing, provides a continuous flow of humidified oxygen directly to the wound bed. This therapy is referred to as Continuous Diffusion of Oxygen (CDO) Therapy and provides full closure and pain relief to patients suffering from chronic wounds.

Visit Product Website

EO2

EO2

EO2 is an advanced wound care technology company and developer of an FDA cleared Class II medical device that provides Continuous Diffusion of Oxygen (CDO) Therapy to difficult-to-heal wounds.

800-825-2979
855-223-6712

OxySpur® Oxygen Diffusion dressing (adhesive and non-adhesive): 2"x2", 4"x5". OxySpur® Lite dressing (adhesive): 2"x8".

• Full closure wound healing—complete re-epithelialization
• Provides Continuous Diffusion of Oxygen (CDO) Therapy to the wound 24 hours per day
• Pain relief
• Simple to use
• Cost effective

The OxyGeni® System provides an oxygen enriched moist environment conducive to wound healing and is indicated to treat lightly to heavily exudating wounds such as: diabetic foot ulcers, venous stasis, post-surgical infections, gangrenous lesions, pressure injuries, infected residual limbs, skin grafts, burns and frostbite.

Contraindicated for use on: wounds with inadequate perfusion to support healing; ulcers due to acute thrombophlebitis; ulcers due to Raynaud's disease; necrotic wounds covered with eschar or slough; wounds with fistulae or deep sinus tracts with unknown depth.

Do not use petroleum-based products in the moist wound bed, as this will prevent oxygen from diffusing into the wound tissue.
The sterile dressings and cannulas are intended for single use only. Do not use after expiration date.
Appropriate supportive measures should be taken where necessary (e.g., use of graduated compression in the management of venous leg ulcers, systemic antibiotics and frequent monitoring in the treatment of wound infection, control of blood glucose for diabetic ulcers, etc.).

Increased drainage, which can be significant in the first few weeks of treatment, often occurs after application of CDO therapy and may require more frequent dressing changes.
In case of intolerance to the dressing, remove and clean the area carefully.
During the body's natural healing process, edema may decrease and non-viable tissue may be removed from the wound (autolytic debridement), which could initially make the wound appear larger. Aggressive debridement is recommended.

Store at room temperature.

Have a product to submit?

Be included in the most comprehensive podiatry products directory and online database.  Learn More

Advertisement